Stock BONEH BBS-BIOACTIVE BONE SUBSTITUTES OYJ
Add to a list
To use this feature you must be a member
Log inSign up

All News BBS-Bioactive Bone Substitutes Oyj

Equities

BONEH

FI4000260583

Market Closed - Nasdaq Helsinki
Other stock markets
 12:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
0.327 EUR -5.49% Intraday chart for BBS-Bioactive Bone Substitutes Oyj -7.63% -33.13%
Jun. 13 BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors CI
Jun. 04 BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BBS-Bioactive Bone Substitutes Plc has resolved on a share issue without consideration to the company itself
AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Municipality of Reisjärvi
AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Finha Capital Oy
AQ
BBS-Bioactive Bone Substitutes Plc plans a share issue to strengthen its equity and will advance the publication date of its half-year report
AQ
BBS-Bioactive Bone Substitutes Plc: Notification pursuant to the Finnish Securities Market Act, Chapter 9, Section 10 - Panvest Oy
AQ
BBS-Bioactive Bone Substitutes Plc: Decisions of the Annual General Meeting 2024
AQ
BBS-Bioactive Bone Substitutes Oyj Approves Election of Gregor Siebert as New Member to the Board of Directors
CI
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
AQ
BBS-Bioactive Bone Substitutes Plc: Claims of the complementary patent application for the ARTEBONE® product have been approved in the USA
AQ
BBS-Bioactive Bone Substitutes Plc Announces Approval of Complementary Patent Application for the ARTEBONE® Product
CI
Notice to the BBS-Bioactive Bone Substitutes Plc’s Annual General Meeting
AQ
BBS-Bioactive Bone Substitutes Plc Announces Ahti Paananen Not Available for Re-Election to the Board of Directors
CI
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024
AQ
BBS-Bioactive Bone Substitutes – Insider information: The company updates the status of the CE marking process
AQ
BBS-Bioactive Bone Substitutes Plc: Annastiina Kauppinen appointed as Financial Manager of BBS-Bioactive Bone Substitutes Plc
AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
AQ
BBS-Bioactive Bone Substitutes Plc: Annual General Meeting in 2024
AQ
BBS-Bioactive Bone Substitutes Plc: Conversion of convertible notes pursuant to financing arrangement between BBS and Riverfort Global Opportunities PCC Ltd
AQ
BBS-Bioactive Bone Substitutes Plc: The website's functionality restored
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BONEH Stock
  4. News BBS-Bioactive Bone Substitutes Oyj